Saltar para: Posts [1], Pesquisa e Arquivos [2]



Noticias de Crohn - Copy.png

Tenho mesmo que ir a Amesterdão experimentar para ver se tem algum efeito! 

 

 

Resumo na língua original:

A 13-year-old boy whose Crohn’s disease and colitis had failed to respond to standard treatments became symptom-free with a combo therapy that included cannabinoids, the cannabinoid therapy maker Vitality Biopharma reported.

 

The study is one of the first to show that cannabinoids can eliminate inflammatory bowel disease (IBD) symptoms in a child or young adult resistant to other therapies, the company said. The research, “Induction of Remission in Drug-Resistant Pediatric Inflammatory Bowel Disease with Cannabinoid Therapy,” has yet to be published in a medical journal.

 

(...)

 

Ler artigo original

 

Autoria e outros dados (tags, etc)

publicado às 15:17

Noticias de Crohn - Copy.png

O National Institute for Health and Care Excellence, no Reino Unido, aprovou a utilização do medicamento Stelara (Ustekinumab) para o tratamento da doença de Crohn. Pelo que pesquisei (que não foi muito, corrijam-me se estiver errado) o Stelara já está a ser utilizado em Portugal para o tratamento de Psoriase. 

 

 

Resumo na língua original:

The NICE Appraisal Committee assess the clinical and cost-effectiveness of drugs for use by the NHS. Subject to there being no appeals, NICE have approved ustekinumab (also called Stelara) for people who have found that conventional therapy or a type of treatment called TNF-alpha inhibitors (infliximab or adalimumab) either don’t work for them, have stopped working or can’t be tolerated.


This important decision comes after Crohn’s and Colitis UK submitted evidence directly to the NICE appraisal committee in March, alongside our nominated patient experts who made powerful personal statements.

 

Ler artigo original

 

Autoria e outros dados (tags, etc)

publicado às 15:17


Pesquisar

  Pesquisar no Blog

Subscrever por e-mail

A subscrição é anónima e gera, no máximo, um e-mail por dia.






subscrever feeds